| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US5891086 | ENDO VENTURES LTD | Needle-less injector |
Jul, 2014
(9 years ago) | |
| US6174304 | ENDO VENTURES LTD | Filling device for a needless injector cartridge |
Dec, 2015
(8 years ago) | |
| US6681810 | ENDO VENTURES LTD | Filling device for a needleless injector cartridge |
Dec, 2015
(8 years ago) | |
| US5957886 | ENDO VENTURES LTD | Spring-Powered dispensing device |
Mar, 2016
(8 years ago) | |
| US6251091 | ENDO VENTURES LTD | Needleless injector drug capsule and filling method |
Dec, 2016
(7 years ago) | |
| US6135979 | ENDO VENTURES LTD | Spring-powered dispensing device for medical purposes |
Mar, 2017
(7 years ago) | |
| US6280410 | ENDO VENTURES LTD | Method of filling a drug capsule and article produced thereby |
Mar, 2017
(7 years ago) | |
| US8343130 | ENDO VENTURES LTD | Needleless injector |
Oct, 2022
(1 year, 6 months ago) | |
| US8491524 | ENDO VENTURES LTD | Needleless injector drug capsule and a method for filling thereof |
Nov, 2022
(1 year, 5 months ago) | |
| US8241244 | ENDO VENTURES LTD | Needleless injector drug capsule and a method for filling thereof |
Nov, 2022
(1 year, 5 months ago) | |
| US8267903 | ENDO VENTURES LTD | Casing |
Mar, 2023
(1 year, 1 month ago) | |
| US8241243 | ENDO VENTURES LTD | Needleless injector drug capsule and a method for filling thereof |
Aug, 2023
(8 months ago) | |
| US8118771 | ENDO VENTURES LTD | Needleless injector drug capsule and a method for filling thereof |
Aug, 2023
(8 months ago) | |
| US8287489 | ENDO VENTURES LTD | Device for readying a needle free injector for delivery |
Dec, 2024
(7 months from now) | |
| US7901385 | ENDO VENTURES LTD | Casing |
Jul, 2026
(2 years from now) | |
| US7776007 | ENDO VENTURES LTD | Device for readying a needle free injector for delivery |
Nov, 2026
(2 years from now) | |
Sumavel Dosepro is owned by Endo Ventures Ltd.
Sumavel Dosepro contains Sumatriptan Succinate.
Sumavel Dosepro has a total of 16 drug patents out of which 13 drug patents have expired.
Expired drug patents of Sumavel Dosepro are:
- US5891086
- US6174304
- US6681810
- US5957886
- US6251091
- US6135979
- US6280410
- US8343130
- US8491524
- US8241244
- US8267903
- US8241243
- US8118771
Sumavel Dosepro was authorised for market use on 26 November, 2013.
Sumavel Dosepro is available in injectable;subcutaneous dosage forms.
The generics of Sumavel Dosepro are possible to be released after 22 November, 2026.
Drugs and Companies using SUMATRIPTAN SUCCINATE ingredient
Market Authorisation Date: 26 November, 2013
Treatment: NA
Dosage: INJECTABLE;SUBCUTANEOUS
SUMAVEL DOSEPRO family patents
